Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases.
暂无分享,去创建一个
S. Dabbs | D. Davies | E. Minthorn | M. Gwynn | B. Bax | R. Markwell | S. Rittenhouse | G. Brooks | P. Brown | Ilaria Giordano | A. Hennessy | G. Jones | N. Pearson | Dongzhao Chen | J. Hoover | T. Miles | B. S. Brown | Nathalie Cailleau | Joel M. Esken | Senthill K Kusalakumari Sukmar